Sayre Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 33

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1M

  • Investors
  • 3

Sayre Therapeutics General Information

Description

Developer of a drug development platform designed to specialize in treating cancer and immunity-related diseases. The company's tool facilitates the development and registration of novel, drug-delivery devices, and companion diagnostics, enabling pharmaceutical companies to commercialize proprietary drugs and medicines for the treatment of cancer.

Contact Information

Website
www.sayretherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 91, 3rd Floor, G.R. Square
  • Amarjyothi Nagar HBCS Layout, Inner Ring road, Domlur
  • Bangalore, Karnataka 560071
  • India
+91 080
Primary Industry
Pharmaceuticals
Vertical(s)
TMT, Life Sciences, Oncology
Corporate Office
  • Number 91, 3rd Floor, G.R. Square
  • Amarjyothi Nagar HBCS Layout, Inner Ring road, Domlur
  • Bangalore, Karnataka 560071
  • India
+91 080

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sayre Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 05-Sep-2017 $1M Completed Generating Revenue
2. Early Stage VC 04-Sep-2017 Completed Generating Revenue
1. Early Stage VC (Series A) 07-Apr-2015 $3.97M $3.97M Completed Generating Revenue
To view Sayre Therapeutics’s complete valuation and funding history, request access »

Sayre Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preference
Ordinary
Preference 79,800 $0.156163 $48.41 $48.41 1x $48.41 34.7%
To view Sayre Therapeutics’s complete cap table history, request access »

Sayre Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug development platform designed to specialize in treating cancer and immunity-related diseases. The co
Pharmaceuticals
Bangalore, India
33 As of 2025

Hyderabad, India
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sayre Therapeutics Competitors (12)

One of Sayre Therapeutics’s 12 competitors is Hetero, a Corporation company based in Hyderabad, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hetero Corporation Hyderabad, India
Alyssum Therapeutics Venture Capital-Backed Cambridge, MA
Laborate Pharmaceuticals India Corporation Panipat, India
Auron Therapeutics Venture Capital-Backed Newton, MA
Intas Pharmaceuticals Private Equity-Backed Ahmedabad, India
You’re viewing 5 of 12 competitors. Get the full list »

Sayre Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sayre Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
InnoVen Capital Lender/Debt Provider
Aarin Capital Partners Venture Capital Minority
Accel Partners Management (Palo Alto) Venture Capital Minority
To view Sayre Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Sayre Therapeutics FAQs

  • When was Sayre Therapeutics founded?

    Sayre Therapeutics was founded in 2015.

  • Where is Sayre Therapeutics headquartered?

    Sayre Therapeutics is headquartered in Bangalore, India.

  • What is the size of Sayre Therapeutics?

    Sayre Therapeutics has 33 total employees.

  • What industry is Sayre Therapeutics in?

    Sayre Therapeutics’s primary industry is Pharmaceuticals.

  • Is Sayre Therapeutics a private or public company?

    Sayre Therapeutics is a Private company.

  • What is Sayre Therapeutics’s current revenue?

    The current revenue for Sayre Therapeutics is .

  • How much funding has Sayre Therapeutics raised over time?

    Sayre Therapeutics has raised $9.2M.

  • Who are Sayre Therapeutics’s investors?

    InnoVen Capital, Aarin Capital Partners, and Accel Partners Management (Palo Alto) have invested in Sayre Therapeutics.

  • Who are Sayre Therapeutics’s competitors?

    Hetero, Alyssum Therapeutics, Laborate Pharmaceuticals India, Auron Therapeutics, and Intas Pharmaceuticals are some of the 12 competitors of Sayre Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »